TherapeuticsMD (TXMD) Accounts Payables (2010 - 2026)
TherapeuticsMD (TXMD) recorded Accounts Payables of $460,000 in Q2 2026, down 71.1% from $1.59 million a year earlier.
Powered by 
Analysis
TherapeuticsMD (TXMD) Accounts Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, TherapeuticsMD reported Accounts Payables of $377,000, up 46.1% from FY2024.
- Annual Accounts Payables has a five-year compound annual growth rate of -55.3% (FY2020 to FY2025).
- Across earlier years, Accounts Payables came in at $258,000 in FY2024 (-91.8%), $3.13 million in FY2023 (-83.4%), $18.85 million in FY2022 (+458.7%) and $3.37 million in FY2021 (-84.0%).
- Quarterly Accounts Payables has ranged from $15,000 in Q1 2026 to $20.75 million in Q1 2022 over the past five years.
- On a year-over-year basis, Accounts Payables rose in two of the last eight quarters, with an average decline of 1.8%.
- Peak year-over-year performance for Accounts Payables in the last five years was growth of 458.7% in Q4 2022, against a decline of 99.2% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $15,000 (Q1 2026), $377,000 (Q4 2025) and $2.02 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.22 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 3.83 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 4.58 Bn |
| 10 | TherapeuticsMD | 21.67 Mn | 21.67 Mn | - | 460,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 460,000.00 |
| Mar 31, 2026 | 15,000.00 |
| Dec 31, 2025 | 377,000.00 |
| Sep 30, 2025 | 2.02 Mn |
| Jun 30, 2025 | 1.59 Mn |
| Mar 31, 2025 | 1.78 Mn |
| Dec 31, 2024 | 258,000.00 |
| Sep 30, 2024 | 2.82 Mn |
| Jun 30, 2024 | 2.68 Mn |
| Mar 31, 2024 | 2.72 Mn |
| Dec 31, 2023 | 3.13 Mn |
| Sep 30, 2023 | 696,000.00 |
| Jun 30, 2023 | 1.51 Mn |
| Mar 31, 2023 | 2.33 Mn |
| Dec 31, 2022 | 18.85 Mn |
| Sep 30, 2022 | 13.38 Mn |
| Jun 30, 2022 | 13.98 Mn |
| Mar 31, 2022 | 20.75 Mn |
| Dec 31, 2021 | 3.37 Mn |
| Sep 30, 2021 | 19.59 Mn |
API Access
TherapeuticsMD Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=TXMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();